JENNIFER MAZUREK: Open Payments
NPI 1679130074 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 45 payments from 12 companies in 2025. Trend: 2023 $283 · 2024 $530 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $164 |
| ABBVIE INC. | 10 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Abbott Laboratories | 4 | $73 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 3 | $45 |
| TOLMAR, INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: TRELEGY ELLIPTA, XIFAXAN, VRAYLAR, FREESTYLE LIBRE 3, UBRELVY, AIRSUPRA, JARDIANCE, BREZTRI.
Industry payments across NC — which companies pay providers there.
